Z-1303-2024 Class II Ongoing

Recalled by Beckman Coulter, Inc. — Chaska, MN

FDA device recall Z-1303-2024 was initiated by Beckman Coulter, Inc. on Feb 8, 2024 and is designated Class II. Reason for recall: Four lots of Access Total T4 reagent lots demonstrated imprecision outside of the 10% specification which may result in erroneous or delayed results. The recall status is ongoing. Affected quantity: 64,009 kits.

Recall Details

Product Type
Devices
Report Date
Mar 27, 2024
Initiation Date
Feb 8, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
64,009 kits

Product Description

Access Total T4, REF 33800, IVD, thyroxine reagent assay.

Reason for Recall

Four lots of Access Total T4 reagent lots demonstrated imprecision outside of the 10% specification which may result in erroneous or delayed results.

Distribution Pattern

Worldwide distribution - US Nationwide, including Puerto Rico and the countries of Bahrain, Bangladesh, Bolivia, Brazil, Canada, China, Croatia, Czech Republic, Denmark, Egypt, El Salvador, Georgia, Greece, Hong Kong, India, Kazakhstan, Mexico, Namibia, Pakistan, Panama, Peru, Philippines, Poland, Portugal, Qatar, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Spain, Taiwan, Thailand, Turkey, U.A.E, Vietnam, and Zimbabwe.

Code Information

Lot numbers: 338555, exp. 31 JUL 2024; 338556, exp. 31 AUG 2024; 338734, exp. 30 SEP 2024; and 338958, exp. 31 OCT 2024; UDI-DI 15099590225742.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1303-2024
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.